Smith & Nephew SNATS, Inc. (NYSE:SNN) to Issue $0.29 Semi-annual Dividend

Key Points

• Smith & Nephew SNATS, Inc. declared a semi-annual dividend of $0.29 to be distributed to shareholders on November 7th, with a dividend yield of 210.0%.
• The company has a dividend payout ratio of 42.0%, indicating strong coverage of its dividend by earnings, with expected future earnings allowing for continued dividend payments.
• Smith & Nephew's stock has been rated as a "hold" by multiple analysts, with a current market capitalization of $15.53 billion and a consensus target price of $28.00.

Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) declared a semi-annual dividend on Wednesday, August 6th, Wall Street Journal reports. Shareholders of record on Friday, October 3rd will be paid a dividend of 0.285 per share by the medical equipment provider on Friday, November 7th. This represents a yield of 210.0%. The ex-dividend date of this dividend is Friday, October 3rd.

Smith & Nephew SNATS has a dividend payout ratio of 42.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Smith & Nephew SNATS to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.92 annual dividend with an expected future payout ratio of 46.0%.

Smith & Nephew SNATS Trading Up 0.1%

SNN stock traded up $0.03 during mid-day trading on Friday, reaching $36.11. The company had a trading volume of 1,334,815 shares, compared to its average volume of 1,073,706. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. The company has a market capitalization of $15.82 billion, a PE ratio of 16.72, a price-to-earnings-growth ratio of 1.10 and a beta of 0.68. The firm has a 50 day moving average of $30.57 and a 200 day moving average of $28.48. Smith & Nephew SNATS has a 12 month low of $23.69 and a 12 month high of $36.56.

Hedge Funds Weigh In On Smith & Nephew SNATS

Hedge funds and other institutional investors have recently modified their holdings of the business. Hexagon Capital Partners LLC lifted its position in Smith & Nephew SNATS by 63.3% during the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 406 shares during the last quarter. Richards Merrill & Peterson Inc. lifted its position in Smith & Nephew SNATS by 500.0% during the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock valued at $34,000 after acquiring an additional 1,000 shares during the last quarter. National Bank of Canada FI lifted its position in Smith & Nephew SNATS by 36.5% during the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock valued at $41,000 after acquiring an additional 446 shares during the last quarter. Bessemer Group Inc. lifted its position in Smith & Nephew SNATS by 3,471.4% during the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 1,701 shares during the last quarter. Finally, Banque Transatlantique SA purchased a new stake in Smith & Nephew SNATS during the first quarter valued at approximately $52,000. 25.64% of the stock is currently owned by institutional investors.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.